Octave 10-Q: Q3 Revenue Up 28% to $85.3M, Net Loss Narrows to $(13.8)M
OSG sits 36% above its 52-week low of $3.88.
Summary
Octave's Q3 10-Q shows revenue up 28% to $85.3 million and the net loss narrowing to $(13.8) million, with the Specialty P&C segment turning profitable even as management warned of a softening market into 2027.
Key Events · Earnings and Guidance · OSG
-
Q3 Revenue Jumps 28%
Total revenue rose to $85.3 million from $66.6 million a year ago, led by 35% growth in Insurance Distribution.
-
Net Loss Narrows Sharply
Net loss attributable to shareholders was $(13.8) million versus $(112.6) million a year ago, which included the discontinued Ambac business.
-
Specialty P&C Turns Profitable
The segment posted $1.4 million pretax income versus a $(0.05) million loss, with the combined ratio improving to 100.6% from 112.9%.
-
Debt Rises on NCI Buyout
Long-term debt climbed to $154.8 million from $117.6 million after a $40 million April 2026 term loan add-on used to fund the redeemable NCI purchase.
Analysis · OSG · Finance
The full 10-Q confirms the turnaround the headline release hinted at: revenue of $85.3 million (up 28%) and a net loss to shareholders of $(13.8) million versus $(112.6) million a year ago, which was inflated by the discontinued Ambac business. The real story is segment-level — Specialty P&C swung to a $1.4 million pretax profit with a 100.6% combined ratio, and Insurance Distribution grew 35%. Against that, management flagged a softening P&C market into 2027, and debt rose to $154.8 million after a $40 million borrowing to buy out minority holders. The quarter shows the reshaped insurance-only company approaching breakeven, but the softening pricing cycle is the risk to watch.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OSG was trading at $5.27 on NYSE in the Finance sector, with a market capitalization of approximately $237.4M. The 52-week trading range was $3.88 to $10.38. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.